SPP1 and osteoporosis: The animal model showed that up-regulated OPN could enhance the activity of ALP, OCN, and BMP-2 in dexamethasone-induced OP, the anti-osteoporosis function of myricetin in vivo may be due to the promoting osteogenic differentiation and matrix mineralization effect caused by OPN (83).